View of Manly Wharf and beach from Spit Road, Sydney.

Conditions We Treat

Blood system (haematological) disorders can be divided into those related to cancer (malignant) and those that are not (non-malignant). Manly Haematology’s focus is on benign disorders, but we also assess and manage selected malignant and pre-malignant conditions.

Benign Disorders

  • Red cell disorders – increased or reduced red cell production, anaemia or polycythaemia; inherited red cell disorders (thalassaemia, sickle cell anaemia)
  • White cell disorders – high or low white cells (leukopenia, leucocytosis)
  • Platelet disorders – high or low platelets, immune thrombocytopaenia (ITP), Von Willebrand disease (VWD)
  • Iron disorders – iron deficiency anaemia, iron overload states including haemochromatosis
  • Hereditary bleeding conditions – haemophilia, and other clotting factor deficiencies
  • Hereditary and acquired clotting conditions – deep venous thrombosis (DVT) and pulmonary emboli (PE); thrombophilia management; management of patients on anticoagulants including duration and perioperative anticoagulant management
  • Obstetric haematology management of women with blood problems during pregnancy – gestational thrombocytopenia
  • Perioperative management of patients with haematological abnormalities

Malignant & Pre-Malignant Disorders

  • Lymphoproliferative disorders – Chronic Lymphocytic Leukaemia (CLL) and Non-Hodgkin’s Lymphomas (NHL)
  • Plasma cell dyscrasias – Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma (MM)
  • Bone marrow disorders – Myelodysplastic Syndromes (MDS) and Aplastic Anaemia (AA)
  • Myeloproliferative disorders – Chronic Myeloid Leukaemia (CML), Polycythaemia Vera (PV), Essential Thrombocythaemia (ET), and Myelofibrosis (PMF)
  • Investigation of splenomegaly or lymphadenopathy

The focus of Manly Haematology is benign (non-cancerous) blood disorders. We also assess and manage patients with certain malignant and pre-malignant conditions, including low-grade leukaemia/lymphoma, myelodysplastic syndromes and Monoclonal Gammopathy of Undetermined Significance (MGUS). Where hospital-based treatment is required – such as blood transfusions, iron infusions, venesections, or inpatient care – we can arrange this through your local tertiary hospital.